| Trial ID: | L0016 |
| Source ID: | NCT06421870
|
| Associated Drug: |
Dapagliflozin 10mg Tab
|
| Title: |
Renoprotective Effects of Dapagliflozin Versus Pentoxiphylline in Chronic Kidney Disease Patients
|
| Acronym: |
|
| Status: |
RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Diseases
|
| Interventions: |
DRUG: Dapagliflozin 10mg Tab|DRUG: Pentoxifylline 400 MG
|
| Outcome Measures: |
Primary: Change in estimated glomerular filtration rate, eGFR will be based on serum creatinine and will be calculated by CKD-EPI 2021, 1 year|Change in proteinuria, Proteinuria quantification done by urine protein to creatinine ratio, 1 year |
|
| Sponsor/Collaborators: |
Sponsor: Ain Shams University
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
210
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2024-03-01
|
| Completion Date: |
2025-07
|
| Results First Posted: |
|
| Last Update Posted: |
2024-05-20
|
| Locations: |
Ain Shams University, Cairo, 1181, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT06421870
|
